• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Medical Polymers Market for Devices, Equipment, Packaging and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 Product Image

Medical Polymers Market for Devices, Equipment, Packaging and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • ID: 3007083
  • October 2014
  • Region: Global
  • 158 Pages
  • Transparency Market Research
Fibers and resins was the largest product type of the medical polymers market and accounted for over 85% of the global share in terms of volume in 2013

FEATURED COMPANIES

  • BASF SE
  • Celanese Corporation
  • Eastman Chemical Company
  • ExxonMobil Corporation
  • INEOS
  • Solvay S.A.
  • MORE

'Medical Polymers (Resins and Fibers (PVC, PP, PE and PS), Elastomers (SBC and Rubber Latex), and Biodegradable Plastics) Market for Devices, Equipment, Packaging and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020'

The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry. Thermoplastic elastomers and rubber latex make up the elastomers segment of the medical polymers market. Biodegradable plastics such as PLA and PEEK are used increasingly due to stringent regulations by authorities such as the Food and Drug Administration (FDA). Growth in emerging economies of Asia Pacific in the medical polymers market is another important factor that is likely to boost product sales over the next few years. Medical polymers are used in the manufacture of devices and equipment in the medical & healthcare segment. Polymers such as polyethylene are used in medical READ MORE >

Fibers and resins was the largest product type of the medical polymers market and accounted for over 85% of the global share in terms of volume in 2013

FEATURED COMPANIES

  • BASF SE
  • Celanese Corporation
  • Eastman Chemical Company
  • ExxonMobil Corporation
  • INEOS
  • Solvay S.A.
  • MORE

Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
1.2.1 Global medical polymers market segmentation
1.3 Research methodology
1.4 Research scope and assumptions

Chapter 2 Executive Summary
2.1 Global medical polymers market, 2013 – 2020 (Kilo Tons) (USD Million)
2.2 Medical polymers - Market snapshot (2013 and 2020)

Chapter 3 Medical Polymers – Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.2.1 Medical polymers: Value chain analysis
3.3 Growth prospects for major polymers
3.4 Market drivers
3.4.1 Increasing demand for medical devices to augment the medical polymer market growth
3.4.1.1 Global medical devices market, 2013 – 2020 (USD Billion)
3.4.2 Growing preference towards home healthcare treatment to boost demand for medical polymers
3.4.2.1 Global medical disposables market, 2013 – 2020 (USD Billion)
3.4.3 Aging population leading to increased demand for medical treatment
3.4.3.1 Global population, by age group, 2010, 2015, and 2020
3.5 Market restraints
3.5.1 Strict regulatory framework governing new product launches to restrain market growth
3.5.2 Increasingly volatile raw material prices likely to impact the growth of the medical polymer market over the forecast period
3.5.2.1 Global crude oil prices, January 2009 – August 2014 (USD per barrel)
3.6 Market opportunities
3.6.1 Increasing importance of biodegradable materials in medical implants provides growth opportunities for medical polymers market
3.6.1.1 Global medical implants market, 2013 – 2020 (USD Billion)
3.7 Porter’s five forces analysis
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat from substitutes
3.7.4 Degree of competition
3.8 Market attractiveness analysis
3.8.1 Medical polymer: Market attractiveness analysis

Chapter 4 Global Medical Polymers Market – Product Segment Analysis
4.1 Global medical polymers market: Product overview
4.1.1 Global medical polymers market volume share, by product, 2013 and 2020
4.2 Fibers and resins
4.2.1 Global medical fibers and resins market volume share, by product, 2013 and 2020
4.2.2 Polyvinyl chloride (PVC)
4.2.2.1 Global PVC fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
4.2.3 Polypropylene (PP)
4.2.3.1 Global PP fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
4.2.4 Polyethylene (PE)
4.2.4.1 Global PE fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
4.2.5 Polystyrene (PS)
4.2.5.1 Global PS fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
4.2.6 Others
4.2.6.1 Global medical fibers and resins market for other polymers, 2013 - 2020 (Kilo Tons) (USD Million)
4.3 Medical elastomers
4.3.1 Global medical elastomers market volume share, by product, 2013 and 2020
4.3.2 Styrenic block copolymer (SBC)
4.3.2.1 Global SBC market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
4.3.3 Rubber latex
4.3.3.1 Global rubber latex market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
4.3.4 Others
4.3.4.1 Global market for other polymers in medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
4.4 Biodegradable plastics
4.4.1 Global biodegradable plastics market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)

Chapter 5 Global Medical Polymers Market – Application Analysis
5.1 Global medical polymers market: Application overview
5.1.1 Global medical polymers market volume share, by application, 2013 and 2020
5.2 Medical devices and equipment
5.2.1 Global medical polymers market for medical devices and equipment, 2013 – 2020 (Kilo Tons) (USD Million)
5.3 Medical packaging
5.3.1 Global medical polymers market for medical packaging, 2013 – 2020 (Kilo Tons) (USD Million)
5.4 Others
5.4.1 Global medical polymers market for other medical applications, 2013 – 2020 (Kilo Tons) (USD Million)

Chapter 6 Global Medical Polymers Market – Regional Analysis
6.1 Global medical polymers market: Regional overview
6.1.1 Global medical polymers market volume share, by region, 2013 and 2020
6.2 North America
6.2.1 North America medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
6.2.2 North America medical polymers market revenue, by product, 2013 – 2020 (USD Million)
6.2.3 North America medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
6.2.4 North America medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
6.2.5 North America medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
6.2.6 North America medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
6.2.7 North America medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
6.2.8 North America medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.3 Europe
6.3.1 Europe medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
6.3.2 Europe medical polymers market revenue, by product, 2013 – 2020 (USD Million)
6.3.3 Europe medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
6.3.4 Europe medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
6.3.5 Europe medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
6.3.6 Europe medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
6.3.7 Europe medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
6.3.8 Europe medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
6.4.2 Asia Pacific medical polymers market revenue, by product, 2013 – 2020 (USD Million)
6.4.3 Asia Pacific medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
6.4.4 Asia Pacific medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
6.4.5 Asia Pacific medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
6.4.6 Asia Pacific medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
6.4.7 Asia Pacific medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
6.4.8 Asia Pacific medical polymers market revenue, by application, 2013 – 2020 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 RoW medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
6.5.2 RoW medical polymers market revenue, by product, 2013 – 2020 (USD Million)
6.5.3 RoW medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
6.5.4 RoW medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
6.5.5 RoW medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
6.5.6 RoW medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
6.5.7 RoW medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
6.5.8 RoW medical polymers market revenue, by application, 2013 – 2020 (USD Million)

Chapter 7 Company Profiles
7.1 BASF SE
7.1.1 Company overview
7.1.2 Product portfolio
7.1.3 Financial overview
7.1.4 Business strategies
7.1.5 Recent developments
7.2 BayerMaterialScience AG
7.2.1 Company overview
7.2.2 Product portfolio
7.2.3 Financial overview
7.2.4 Business strategy
7.2.5 Recent developments
7.3 Celanese Corporation
7.3.1 Company overview
7.3.2 Product portfolio
7.3.3 Financial overview
7.3.4 Business strategy
7.3.5 Recent developments
7.4 DSM N.V.
7.4.1 Company overview
7.4.2 Product portfolio
7.4.3 Financial overview
7.4.4 Business strategy
7.4.5 Recent developments
7.5 E. I. du Pont de Nemours Company
7.5.1 Company overview
7.5.2 Product portfolio
7.5.3 Financial overview
7.5.4 Business strategy
7.5.5 Recent developments
7.6 Eastman Chemical Company
7.6.1 Company overview
7.6.2 Product portfolio
7.6.3 Financial overview
7.6.4 Business strategy
7.6.5 Recent developments
7.7 Evonik Industries AG
7.7.1 Company overview
7.7.2 Product portfolio
7.7.3 Financial overview
7.7.4 Business strategy
7.7.5 Recent developments
7.8 ExxonMobil Corporation
7.8.1 Company overview
7.8.2 Product portfolio
7.8.3 Financial overview
7.8.4 Business strategy
7.8.5 Recent developments
7.9 The Dow Chemical Company
7.9.1 Company overview
7.9.2 Product portfolio
7.9.3 Financial overview
7.9.4 Business strategy
7.9.5 Recent developments
7.10 Huizhou Foryou Medical Device Co., Ltd.
7.10.1 Company overview
7.10.2 Product portfolio
7.10.3 Business strategy
7.10.4 Recent developments
7.11 Kraton Performance Polymers, Inc.
7.11.1 Company overview
7.11.2 Product portfolio
7.11.3 Financial overview
7.11.4 Business strategy
7.11.5 Recent developments
7.12 Tianjin Plastics Research Institute Co., Ltd.
7.12.1 Company overview
7.12.2 Product portfolio
7.12.3 Business strategy
7.13 Formosa Plastics Corporation, U.S.A.
7.13.1 Company overview
7.13.2 Product portfolio
7.13.3 Business strategy
7.13.4 Recent developments
7.14 Shanghai New Shanghua Polymer Material Co., Ltd.
7.14.1 Company overview
7.14.2 Product portfolio
7.14.3 Business strategy
7.15 Sinopec Beijing Yanshan Company
7.15.1 Company overview
7.15.2 Product portfolio
7.15.3 Business strategy
7.15.4 Recent development
7.16 Ningbo Yonghua Resin Co. Ltd.
7.16.1 Company overview
7.16.2 Product portfolio
7.16.3 Business strategy
7.16.4 Recent developments
7.17 SINOPEC Shanghai Petrochemical Co. Ltd.
7.17.1 Company overview
7.17.2 Product portfolio
7.17.3 Financial overview
7.17.4 Business strategy
7.17.5 Recent developments
7.18 SABIC’s Innovative Plastics
7.18.1 Company overview
7.18.2 Product portfolio
7.18.3 Business strategy
7.18.4 Recent developments
7.19 Lubrizol Corporation
7.19.1 Company overview
7.19.2 Product portfolio
7.19.3 Business strategy
7.19.4 Recent developments
7.20 HBM Piaoan Medical Dressing. Inc
7.20.1 Company overview
7.20.2 Product portfolio
7.20.3 Business strategy
7.20.4 Recent developments
7.21 Victrex plc
7.21.1 Company overview
7.21.2 Product portfolio
7.21.3 Financial overview
7.21.4 Business strategy
7.21.5 Recent developments
7.22 Huntsman Corporation
7.22.1 Company overview
7.22.2 Product portfolio
7.22.3 Financial overview
7.22.4 Business strategy
7.22.5 Recent developments
7.23 China Haohua Chemical Group Co., Ltd.
7.23.1 Company overview
7.23.2 Business strategy
7.23.3 Recent developments
7.24 INEOS
7.24.1 Company overview
7.24.2 Product portfolio
7.24.3 Business strategy
7.24.4 Recent developments
7.25 Jafron Biomedical Co., Ltd.
7.25.1 Company overview
7.25.2 Product portfolio
7.25.3 Business strategy
7.25.4 Recent developments
7.26 Solvay S.A.
7.26.1 Company overview
7.26.2 Product portfolio
7.26.3 Financial overview
7.26.4 Business strategy
7.26.5 Recent developments
7.27 WEIGAO Holding Co., Ltd. (WEGO)
7.27.1 Company overview
7.27.2 Product portfolio
7.27.3 Financial overview
7.27.4 Business strategy
7.27.5 Recent developments

List of Figures:

FIG. 1 Global medical polymers market segmentation
FIG. 2 Global medical polymers market, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 3 Medical polymers: Value chain analysis
FIG. 4 Global medical devices market, 2013 – 2020 (USD Billion)
FIG. 5 Global medical disposables market, 2013 – 2020 (USD Billion)
FIG. 6 Global population, by age group, 2010, 2015, and 2020
FIG. 7 Global crude oil prices, January 2009 – August 2014 (USD per barrel)
FIG. 8 Global medical implants market, 2013 – 2020 (USD Billion)
FIG. 9 Medical polymers: Porter’s five forces analysis
FIG. 10 Medical polymer: Market attractiveness analysis
FIG. 11 Global medical polymers market volume share, by product, 2013 and 2020
FIG. 12 Global medical fibers and resins market volume share, by product, 2013 and 2020
FIG. 13 Global PVC fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 14 Global PP fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 15 Global PE fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 16 Global PS fibers and resins market for medical application, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 17 Global medical fibers and resins market for other polymers, 2013 - 2020 (Kilo Tons) (USD Million)
FIG. 18 Global medical elastomers market volume share, by product, 2013 and 2020
FIG. 19 Global SBC market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 20 Global rubber latex market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 21 Global market for other polymers in medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 22 Global biodegradable plastics market for medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 23 Global medical polymers market volume share, by application, 2013 and 2020
FIG. 24 Global medical polymers market for medical devices and equipment, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 25 Global medical polymers market for medical packaging, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 26 Global medical polymers market other medical applications, 2013 – 2020 (Kilo Tons) (USD Million)
FIG. 27 Global medical polymers market volume share, by region, 2013 and 2020

List of Tables:

TABLE 1 Medical polymers market: Global snapshot
TABLE 2 Market potential for medical polymers
TABLE 3 Drivers for medical polymer market: Impact analysis
TABLE 4 Restraints for medical polymers market: Impact analysis
TABLE 5 North America medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 6 North America medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 7 North America medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 8 North America medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 9 North America medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 10 North America medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 11 North America medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 12 North America medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 13 Europe medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 14 Europe medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 15 Europe medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 16 Europe medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 17 Europe medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 18 Europe medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 19 Europe medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 20 Europe medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 21 Asia Pacific medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 22 Asia Pacific medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 23 Asia Pacific medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 24 Asia Pacific medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 25 Asia Pacific medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 26 Asia Pacific medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 27 Asia Pacific medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 28 Asia Pacific medical polymers market revenue, by application, 2013 – 2020 (USD Million)
TABLE 29 RoW medical polymers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 30 RoW medical polymers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 31 RoW medical fibers and resins market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 32 RoW medical fibers and resins market revenue, by product, 2013 – 2020 (USD Million)
TABLE 33 RoW medical elastomers market volume, by product, 2013 – 2020 (Kilo Tons)
TABLE 34 RoW medical elastomers market revenue, by product, 2013 – 2020 (USD Million)
TABLE 35 RoW medical polymers market volume, by application, 2013 – 2020 (Kilo Tons)
TABLE 36 RoW medical polymers market revenue, by application, 2013 – 2020 (USD Million)

Fibers and resins was the largest product type of the medical polymers market and accounted for over 85% of the global share in terms of volume in 2013

FEATURED COMPANIES

  • BASF SE
  • Celanese Corporation
  • Eastman Chemical Company
  • ExxonMobil Corporation
  • INEOS
  • Solvay S.A.
  • MORE

Polymers such as resins and fibers, elastomers such as natural rubber and thermoplastic elastomers and biodegradable plastics used in various forms in medical and healthcare applications are collectively known as medical polymers. Traditionally, metals, glass and ceramics have been used as medical implants, devices and supports. However, polymers are more suitable for these applications due to lesser weight, better biocompatibility and lower cost. Medical polymers are used majorly in devices and equipment such as spinal implants, hip & joint replacements, and implants for cranial injuries. These are also used in various types of medical packaging.

Fibers and resins used as medical polymers include materials such as polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS) and others such as nylon, polyethylene terephthalate (PET) and polyamide (PA). Medical elastomers such as styrene block copolymers (SBCs), polyurethane (PU), natural rubber or latex, silicone and butyl rubber are used in numerous applications in implants and joint replacements. Legislative issues regarding the supply side of the medical polymers market were one or the primary concerns of material suppliers. However, the onus of responsibility has been transferred onto component and device manufacturers by the Food & Drug Administration (FDA) of late. This has helped material suppliers produce extensive grades of medical polymers for numerous purposes. Commodity resins such as PE, PP, PVC, PS and PET are the most widely used polymers in medical applications. These account for majority of the market share. At the same time, demand for other materials such as nylon, polycarbonate (PC) and acrylonitrile butadiene styrene (ABS) is expected to increase in the near future.

Rising demand for medical devices, increasing preference for home healthcare treatment and growth in aging population are some of the key factors likely to boost demand for medical polymers. Additionally, rising usage of disposable medical devices is expected to augment demand for medical polymers. Over the past few years, polymers have been increasingly substituting traditional materials such as metals in packaging of medical devices, equipment and pharmaceuticals owing to their biocompatibility and lightness in weight. Demand for polymers in medical packaging applications is anticipated to be significantly high over the next few years due to advancement in material science and increased measures for packaging for safety purposes. However, presence of stringent regulations regarding new product launches in the sensitive industry coupled with volatility in prices of raw materials such as crude oil is anticipated to hamper the medical polymers market in the near future. Rising consumer awareness regarding biodegradable materials in plastic implants is estimated to offer new opportunities for market growth.

Fibers and resins was the largest product type of the medical polymers market and accounted for over 85% of the global share in terms of volume in 2013. Biodegradable plastic is expected to be the fastest growing segment of the market during the forecast period. Rising need for biocompatible materials, particularly in implants, is anticipated to drive demand for biodegradable polymers in the near future. Elastomers and fibers and resins are likely to lose their market shares to biodegradable plastics during the forecast period. However, fibers and resins are expected to remain the majorly used products in the medical sector during the forecast period.

Together, medical devices and equipment, and medical packaging accounted for 90% of the global medical polymers market in terms of volume in 2013. Increasing number of health issues due to lifestyle changes has led to a higher demand for medical procedures. Additionally, The cardiovascular segment is expanding due to rising number of heart patients. This coupled with growth in surgical and infection control cases in Asia Pacific is boosting the demand for polymers in medical devices. The medical device packaging industry is expected to grow in emerging countries such as India and China where expansion, diversification and stricter regulations of the medical product industry are raising the functional and quality requirements of containers and related accessories. Furthermore, demand for polymers as coronary stents is rising steadily due to increasing prevalence of cardiovascular diseases.

North America was the largest market for medical polymers in 2013, accounting for over 40% share of the global medical polymers market. The region was followed by Europe, which constituted over 25% share in the same year. Asia Pacific is anticipated to experience the fastest growth in the medical polymers market during the forecast period, followed by Rest of the World, due to various factors such as increasing awareness regarding general well-being among consumers, improved medical infrastructure and easy availability of medical services. Demand for medical polymers is estimated to be high in North America and Europe; however, the developed regions are expected to lose their market shares to developing economies of Asia Pacific and Rest of the World due to significant demand for medical polymers in these regions.

Fibers and resins was the largest product type of the medical polymers market and accounted for over 85% of the global share in terms of volume in 2013

- BASF SE
- BayerMaterialScience AG
- Celanese Corporation
- China Haohua Chemical Group Co., Ltd.
- DSM N.V.
- E. I. du Pont de Nemours Company
- Eastman Chemical Company
- Evonik Industries AG
- ExxonMobil Corporation
- Formosa Plastics Corporation, U.S.A.
- HBM Piaoan Medical Dressing. Inc
- Huizhou Foryou Medical Device Co., Ltd.
- Huntsman Corporation
- INEOS
- Jafron Biomedical Co., Ltd.
- Kraton Performance Polymers, Inc.
- Lubrizol Corporation
- Ningbo Yonghua Resin Co. Ltd.
- SABIC’s Innovative Plastics
- SINOPEC Shanghai Petrochemical Co. Ltd.
- Shanghai New Shanghua Polymer Material Co., Ltd.
- Sinopec Beijing Yanshan Company
- Solvay S.A.
- The Dow Chemical Company
- Tianjin Plastics Research Institute Co., Ltd.
- Victrex plc
- WEIGAO Holding Co., Ltd. (WEGO)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos